Evidence map›Paper›PMID 31164826›Full record

ArticleFrontiers in pharmacology2019

1-Deoxynojirimycin in Mulberry (

Yan Ma, Wei Lv, Yan Gu, Shui Yu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Compounds of plants with activity against SARS-CoV-2 targets.Expert review of clinical pharmacology · 2021
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Contribution of Extracellular Particles Isolated fromInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ.Journal of inflammation (London, England) · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Tuning the activity of iminosugars: novelJournal of enzyme inhibition and medicinal chemistry · 2021
    Article
  19. The Synergistic Effects ofDrug design, development and therapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yan MaDepartment of Cardiovascular, The First Hospital of Jilin University, Changchun, China.
Wei LvDepartment of Cadre Ward, Seven Therapy Area, The First Hospital of Jilin University, Changchun, China.
Yan GuDepartment of Cardiovascular, The First Hospital of Jilin University, Changchun, China.
Shui YuDepartment of Cardiovascular, The First Hospital of Jilin University, Changchun, China.
First Hospital of Jilin University · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

1-deoxynojirimycinangina pectorisblood stasis syndromecoronary heart diseasemulberry leaves

Identifiers

PMID31164826
PMCPMC6536649
OpenAlexW2944205839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.